🇺🇸 FDA
Pipeline program

VERDYE 5 mg/ml poeder voor oplossing voor injectie

Phase 3 small_molecule active

Quick answer

VERDYE 5 mg/ml poeder voor oplossing voor injectie for Histologically confirmed solid malignancy (e.g., head and neck, gastrointestinal, hepatobiliary, breast, genitourinary, sarcoma) is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Histologically confirmed solid malignancy (e.g., head and neck, gastrointestinal, hepatobiliary, breast, genitourinary, sarcoma)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials